General Practice · Burbank, CA
NPI
1992981161
Since 2008
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
421 E Angeleno Ave Ste 102
Burbank, CA, 91501
Phone (818) 845-6800
Medicare paid, 2024
$415K
9,889 services
Medicare patients, 2024
504
Average age 76
Drug cost, 2024
$2.8M
23,316 prescriptions
Company payments, 2025
$2,045
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip H Lee was code 99213 (office e&m - established), 3,785 times for 456 patients. In total Philip H Lee billed 9,889 services in 80 codes, and Medicare paid $415K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 3,785 | 456 | $70.66 | $267K |
| 98926 Spinal Manipulation | Office | 1,042 | 320 | $35.27 | $37K |
| 97110 PT Treatment | Office | 507 | 210 | $21.69 | $11K |
| 97012 PT Treatment | Office | 409 | 207 | $8.58 | $3,509 |
| 97016 PT Treatment | Office | 396 | 199 | $6.72 | $2,661 |
| 97024 PT Treatment | Office | 390 | 194 | $3.72 | $1,453 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 345 | 174 | $0.08 | $28.4 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 332 | 170 | $0.31 | $102 |
| 99442 Telephone Services | Office | 297 | 193 | $47.96 | $14K |
| 71046 X-ray - Chest | Office | 243 | 159 | $27.51 | $6,684 |
| 99214 Office E&M - Established | Office | 192 | 117 | $96.75 | $19K |
| 97814 Treatment - Miscellaneous | Office | 171 | 17 | $31.56 | $5,396 |
| 97530 PT Treatment | Office | 135 | 17 | $32.32 | $4,364 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 132 | 72 | $0.91 | $120 |
| 36415 Venipuncture Blood Collection | Office | 118 | 110 | $8.65 | $1,021 |
By year: 2022 $178K for 10,864 services; 2023 $495K for 16,386 services; 2024 $415K for 9,889 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 118 | 110 | $8.65 | $1,021 |
Medicare prescription drug claims, 2024
In 2024, the drug Philip H Lee prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,304 prescriptions and refills. In total Philip H Lee wrote 23,316 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,304 | 1,867 | 274 | $4,909 |
| Amlodipine Besylate Generic | 1,168 | 1,631 | 198 | $1,968 |
| Losartan Potassium Generic | 637 | 919 | 115 | $2,616 |
| Vascepa Icosapent Ethyl | 601 | 665 | 106 | $220K |
| Metformin Hcl Generic | 529 | 724 | 104 | $42K |
| Omeprazole Generic | 525 | 607 | 146 | $1,488 |
| Azithromycin Generic | 497 | 497 | 269 | $1,102 |
| Icosapent Ethyl Generic | 470 | 536 | 134 | $98K |
| Amoxicillin Generic | 466 | 466 | 249 | $1,246 |
| Alendronate Sodium Generic | 404 | 469 | 81 | $1,076 |
| Tamsulosin Hcl Generic | 399 | 569 | 86 | $2,217 |
| Triamcinolone Acetonide Generic | 379 | 386 | 141 | $3,789 |
| Lisinopril Generic | 366 | 545 | 68 | $1,097 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 287 | 404 | 135 | $8,743 |
| Rosuvastatin Calcium Generic | 279 | 359 | 52 | $1,175 |
Brand drugs: 3,658 claims; generic drugs: 19,431 claims; opioid claims: 200.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Philip H Lee $2,045 ($2,045 in general payments such as food, travel and fees) from 19 companies. The largest payer was Ardelyx, Inc. with $378.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 15 | $378 |
| Verona Pharma, Inc. VRNA | 11 | $314 |
| Amgen Inc. AMGN | 8 | $232 |
| GlaxoSmithKline, LLC. GSK | 5 | $167 |
| Dexcom, Inc. DXCM | 6 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $124 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $118 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $107 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $82.1 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $81.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.